United States Ethinyl Estradiol and Levonorgestrel Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Ethinyl Estradiol and Levonorgestrel Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Ethinyl Estradiol and Levonorgestrel Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Ethinyl Estradiol and Levonorgestrel Overall Market Size
2.1 United States Ethinyl Estradiol and Levonorgestrel Market Size: 2021 VS 2027
2.2 United States Ethinyl Estradiol and Levonorgestrel Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Ethinyl Estradiol and Levonorgestrel Sales: 2016-2027
3 Company Landscape
3.1 Top Ethinyl Estradiol and Levonorgestrel Players in United States Market
3.2 Top United States Ethinyl Estradiol and Levonorgestrel Companies Ranked by Revenue
3.3 United States Ethinyl Estradiol and Levonorgestrel Revenue by Companies
3.4 United States Ethinyl Estradiol and Levonorgestrel Sales by Companies
3.5 United States Ethinyl Estradiol and Levonorgestrel Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Ethinyl Estradiol and Levonorgestrel Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Ethinyl Estradiol and Levonorgestrel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ethinyl Estradiol and Levonorgestrel Players in United States Market
3.8.1 List of Tier 1 Ethinyl Estradiol and Levonorgestrel Companies in United States
3.8.2 List of Tier 2 and Tier 3 Ethinyl Estradiol and Levonorgestrel Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Ethinyl Estradiol and Levonorgestrel Market Size Markets, 2021 & 2027
4.1.2 0.02mg/0.1mg
4.1.3 0.03mg/0.15mg
4.1.4 0.01mg/0.15mg
4.1.5 0.02mg/0.09mg
4.2 By Type - United States Ethinyl Estradiol and Levonorgestrel Revenue & Forecasts
4.2.1 By Type - United States Ethinyl Estradiol and Levonorgestrel Revenue, 2016-2021
4.2.2 By Type - United States Ethinyl Estradiol and Levonorgestrel Revenue, 2022-2027
4.2.3 By Type - United States Ethinyl Estradiol and Levonorgestrel Revenue Market Share, 2016-2027
4.3 By Type - United States Ethinyl Estradiol and Levonorgestrel Sales & Forecasts
4.3.1 By Type - United States Ethinyl Estradiol and Levonorgestrel Sales, 2016-2021
4.3.2 By Type - United States Ethinyl Estradiol and Levonorgestrel Sales, 2022-2027
4.3.3 By Type - United States Ethinyl Estradiol and Levonorgestrel Sales Market Share, 2016-2027
4.4 By Type - United States Ethinyl Estradiol and Levonorgestrel Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Ethinyl Estradiol and Levonorgestrel Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Drug Store
5.2 By Application - United States Ethinyl Estradiol and Levonorgestrel Revenue & Forecasts
5.2.1 By Application - United States Ethinyl Estradiol and Levonorgestrel Revenue, 2016-2021
5.2.2 By Application - United States Ethinyl Estradiol and Levonorgestrel Revenue, 2022-2027
5.2.3 By Application - United States Ethinyl Estradiol and Levonorgestrel Revenue Market Share, 2016-2027
5.3 By Application - United States Ethinyl Estradiol and Levonorgestrel Sales & Forecasts
5.3.1 By Application - United States Ethinyl Estradiol and Levonorgestrel Sales, 2016-2021
5.3.2 By Application - United States Ethinyl Estradiol and Levonorgestrel Sales, 2022-2027
5.3.3 By Application - United States Ethinyl Estradiol and Levonorgestrel Sales Market Share, 2016-2027
5.4 By Application - United States Ethinyl Estradiol and Levonorgestrel Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Overview
6.1.3 Teva Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.1.4 Teva Ethinyl Estradiol and Levonorgestrel Product Description
6.1.5 Teva Recent Developments
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Overview
6.2.3 Pfizer Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.2.4 Pfizer Ethinyl Estradiol and Levonorgestrel Product Description
6.2.5 Pfizer Recent Developments
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Overview
6.3.3 Aurobindo Pharma Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.3.4 Aurobindo Pharma Ethinyl Estradiol and Levonorgestrel Product Description
6.3.5 Aurobindo Pharma Recent Developments
6.4 Laboratorios Leon Farma
6.4.1 Laboratorios Leon Farma Corporation Information
6.4.2 Laboratorios Leon Farma Overview
6.4.3 Laboratorios Leon Farma Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.4.4 Laboratorios Leon Farma Ethinyl Estradiol and Levonorgestrel Product Description
6.4.5 Laboratorios Leon Farma Recent Developments
6.5 Glenmark
6.5.1 Glenmark Corporation Information
6.5.2 Glenmark Overview
6.5.3 Glenmark Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.5.4 Glenmark Ethinyl Estradiol and Levonorgestrel Product Description
6.5.5 Glenmark Recent Developments
6.6 Allergan
6.6.1 Allergan Corporation Information
6.6.2 Allergan Overview
6.6.3 Allergan Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.6.4 Allergan Ethinyl Estradiol and Levonorgestrel Product Description
6.6.5 Allergan Recent Developments
6.7 Avion Pharmaceuticals
6.7.1 Avion Pharmaceuticals Corporation Information
6.7.2 Avion Pharmaceuticals Overview
6.7.3 Avion Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.7.4 Avion Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Product Description
6.7.5 Avion Pharmaceuticals Recent Developments
6.8 LUPIN
6.8.1 LUPIN Corporation Information
6.8.2 LUPIN Overview
6.8.3 LUPIN Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.8.4 LUPIN Ethinyl Estradiol and Levonorgestrel Product Description
6.8.5 LUPIN Recent Developments
6.9 Mayne Pharma
6.9.1 Mayne Pharma Corporation Information
6.9.2 Mayne Pharma Overview
6.9.3 Mayne Pharma Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.9.4 Mayne Pharma Ethinyl Estradiol and Levonorgestrel Product Description
6.9.5 Mayne Pharma Recent Developments
6.10 Novast
6.10.1 Novast Corporation Information
6.10.2 Novast Overview
6.10.3 Novast Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.10.4 Novast Ethinyl Estradiol and Levonorgestrel Product Description
6.10.5 Novast Recent Developments
6.11 Mylan
6.11.1 Mylan Corporation Information
6.11.2 Mylan Overview
6.11.3 Mylan Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.11.4 Mylan Ethinyl Estradiol and Levonorgestrel Product Description
6.11.5 Mylan Recent Developments
6.12 Amneal Pharmaceuticals
6.12.1 Amneal Pharmaceuticals Corporation Information
6.12.2 Amneal Pharmaceuticals Overview
6.12.3 Amneal Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Sales and Revenue in United States Market (2016-2021)
6.12.4 Amneal Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Product Description
6.12.5 Amneal Pharmaceuticals Recent Developments
7 United States Ethinyl Estradiol and Levonorgestrel Production Capacity, Analysis
7.1 United States Ethinyl Estradiol and Levonorgestrel Production Capacity, 2016-2027
7.2 Ethinyl Estradiol and Levonorgestrel Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Ethinyl Estradiol and Levonorgestrel Supply Chain Analysis
9.1 Ethinyl Estradiol and Levonorgestrel Industry Value Chain
9.2 Ethinyl Estradiol and Levonorgestrel Upstream Market
9.3 Ethinyl Estradiol and Levonorgestrel Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Ethinyl Estradiol and Levonorgestrel Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Ethinyl Estradiol and Levonorgestrel in United States Market
Table 2. Top Ethinyl Estradiol and Levonorgestrel Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Ethinyl Estradiol and Levonorgestrel Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Ethinyl Estradiol and Levonorgestrel Revenue Share by Companies, 2016-2021
Table 5. United States Ethinyl Estradiol and Levonorgestrel Sales by Companies, (K Units), 2016-2021
Table 6. United States Ethinyl Estradiol and Levonorgestrel Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Ethinyl Estradiol and Levonorgestrel Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Ethinyl Estradiol and Levonorgestrel Product Type
Table 9. List of Tier 1 Ethinyl Estradiol and Levonorgestrel Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Ethinyl Estradiol and Levonorgestrel Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of 0.02mg/0.1mg
Table 12. Major Manufacturers of 0.03mg/0.15mg
Table 13. By Type - United States Ethinyl Estradiol and Levonorgestrel Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Ethinyl Estradiol and Levonorgestrel Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Ethinyl Estradiol and Levonorgestrel Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Ethinyl Estradiol and Levonorgestrel Sales (K Units), 2016-2021
Table 17. By Type - United States Ethinyl Estradiol and Levonorgestrel Sales (K Units), 2022-2027
Table 18. By Application - United States Ethinyl Estradiol and Levonorgestrel Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Ethinyl Estradiol and Levonorgestrel Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Ethinyl Estradiol and Levonorgestrel Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Ethinyl Estradiol and Levonorgestrel Sales (K Units), 2016-2021
Table 22. By Application - United States Ethinyl Estradiol and Levonorgestrel Sales (K Units), 2022-2027
Table 23. Teva Corporation Information
Table 24. Teva Description and Major Businesses
Table 25. Teva Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Teva Ethinyl Estradiol and Levonorgestrel Product
Table 27. Teva Recent Developments
Table 28. Pfizer Corporation Information
Table 29. Pfizer Description and Major Businesses
Table 30. Pfizer Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Pfizer Ethinyl Estradiol and Levonorgestrel Product
Table 32. Pfizer Recent Developments
Table 33. Aurobindo Pharma Corporation Information
Table 34. Aurobindo Pharma Description and Major Businesses
Table 35. Aurobindo Pharma Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Aurobindo Pharma Ethinyl Estradiol and Levonorgestrel Product
Table 37. Aurobindo Pharma Recent Developments
Table 38. Laboratorios Leon Farma Corporation Information
Table 39. Laboratorios Leon Farma Description and Major Businesses
Table 40. Laboratorios Leon Farma Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Laboratorios Leon Farma Ethinyl Estradiol and Levonorgestrel Product
Table 42. Laboratorios Leon Farma Recent Developments
Table 43. Glenmark Corporation Information
Table 44. Glenmark Description and Major Businesses
Table 45. Glenmark Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Glenmark Ethinyl Estradiol and Levonorgestrel Product
Table 47. Glenmark Recent Developments
Table 48. Allergan Corporation Information
Table 49. Allergan Description and Major Businesses
Table 50. Allergan Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Allergan Ethinyl Estradiol and Levonorgestrel Product
Table 52. Allergan Recent Developments
Table 53. Avion Pharmaceuticals Corporation Information
Table 54. Avion Pharmaceuticals Description and Major Businesses
Table 55. Avion Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Avion Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Product
Table 57. Avion Pharmaceuticals Recent Developments
Table 58. LUPIN Corporation Information
Table 59. LUPIN Description and Major Businesses
Table 60. LUPIN Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. LUPIN Ethinyl Estradiol and Levonorgestrel Product
Table 62. LUPIN Recent Developments
Table 63. Mayne Pharma Corporation Information
Table 64. Mayne Pharma Description and Major Businesses
Table 65. Mayne Pharma Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Mayne Pharma Ethinyl Estradiol and Levonorgestrel Product
Table 67. Mayne Pharma Recent Developments
Table 68. Novast Corporation Information
Table 69. Novast Description and Major Businesses
Table 70. Novast Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Novast Ethinyl Estradiol and Levonorgestrel Product
Table 72. Novast Recent Developments
Table 73. Mylan Corporation Information
Table 74. Mylan Description and Major Businesses
Table 75. Mylan Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 76. Mylan Ethinyl Estradiol and Levonorgestrel Product
Table 77. Mylan Recent Developments
Table 78. Amneal Pharmaceuticals Corporation Information
Table 79. Amneal Pharmaceuticals Description and Major Businesses
Table 80. Amneal Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 81. Amneal Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Product
Table 82. Amneal Pharmaceuticals Recent Developments
Table 83. Ethinyl Estradiol and Levonorgestrel Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 84. United States Ethinyl Estradiol and Levonorgestrel Capacity Market Share of Key Manufacturers, 2019-2021
Table 85. Ethinyl Estradiol and Levonorgestrel Market Opportunities & Trends in United States Market
Table 86. Ethinyl Estradiol and Levonorgestrel Market Drivers in United States Market
Table 87. Ethinyl Estradiol and Levonorgestrel Market Restraints in United States Market
Table 88. Ethinyl Estradiol and Levonorgestrel Raw Materials
Table 89. Ethinyl Estradiol and Levonorgestrel Raw Materials Suppliers in United States Market
Table 90. Typical Ethinyl Estradiol and Levonorgestrel Downstream
Table 91. Ethinyl Estradiol and Levonorgestrel Downstream Clients in United States Market
Table 92. Ethinyl Estradiol and Levonorgestrel Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Ethinyl Estradiol and Levonorgestrel Product Picture
Figure 2. Ethinyl Estradiol and Levonorgestrel Segment by Type
Figure 3. Ethinyl Estradiol and Levonorgestrel Segment by Application
Figure 4. United States Ethinyl Estradiol and Levonorgestrel Market Overview: 2020
Figure 5. United States Ethinyl Estradiol and Levonorgestrel Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Ethinyl Estradiol and Levonorgestrel Revenue, 2016-2027 (US$, Mn)
Figure 7. Ethinyl Estradiol and Levonorgestrel Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Ethinyl Estradiol and Levonorgestrel Revenue in 2020
Figure 9. 0.02mg/0.1mg Product Picture
Figure 10. 0.03mg/0.15mg Product Picture
Figure 11. 0.01mg/0.15mg Product Picture
Figure 12. 0.02mg/0.09mg Product Picture
Figure 13. By Type - United States Ethinyl Estradiol and Levonorgestrel Sales Market Share, 2016-2027
Figure 14. By Type - United States Ethinyl Estradiol and Levonorgestrel Revenue Market Share, 2016-2027
Figure 15. By Type - United States Ethinyl Estradiol and Levonorgestrel Price (USD/Unit), 2016-2027
Figure 16. Hospital
Figure 17. Drug Store
Figure 18. By Application - United States Ethinyl Estradiol and Levonorgestrel Sales Market Share, 2016-2027
Figure 19. By Application - United States Ethinyl Estradiol and Levonorgestrel Revenue Market Share, 2016-2027
Figure 20. By Application - United States Ethinyl Estradiol and Levonorgestrel Price (USD/Unit), 2016-2027
Figure 21. Teva Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Pfizer Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Aurobindo Pharma Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Laboratorios Leon Farma Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Glenmark Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Allergan Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Avion Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. LUPIN Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Mayne Pharma Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Novast Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Mylan Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Amneal Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. United States Ethinyl Estradiol and Levonorgestrel Production Capacity (K Units), 2016-2027
Figure 34. Ethinyl Estradiol and Levonorgestrel Industry Value Chain
Figure 35. Marketing Channels